<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1294">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05144308</url>
  </required_header>
  <id_info>
    <org_study_id>JFO_2021_10</org_study_id>
    <nct_id>NCT05144308</nct_id>
  </id_info>
  <brief_title>Assessment of Visual and Refractive Results and Rotational Stability of the TECNIS® Eyhance Toric II 1-piece Posterior Chamber Lens in Patients With Astigmatism Undergoing Cataract Surgery</brief_title>
  <acronym>STATE</acronym>
  <official_title>Assessment of Visual and Refractive Results, and Rotational Stability of the TECNIS® Eyhance Toric II 1-piece Posterior Chamber Lens in Patients With Astigmatism Undergoing Cataract Surgery: a Prospective Cohort Study - STATE</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Johnson &amp; Johnson</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cataract surgery is one of the most common procedures performed worldwide. Astigmatism is the&#xD;
      most common refractive disorder in adults, hence there is a high prevalence of preexisting&#xD;
      astigmatism in cataract patients. Access to astigmatism correction during cataract surgery&#xD;
      allows for improved visual outcomes for patients. Toric intraocular lenses (IOLs) are the&#xD;
      procedure of choice to correct corneal astigmatism of one diopter or more in cases undergoing&#xD;
      cataract surgery. Rotational stability is a key factor for successful outcomes with toric&#xD;
      IOLs. Postoperative toric IOL misalignment is the major factor responsible for suboptimal&#xD;
      visual outcomes after toric IOL implantation.&#xD;
&#xD;
      The TECNIS® Eyhance Toric II 1-piece posterior chamber lens is a new toric IOL which is FDA&#xD;
      approved and CE marked. Marketed by Johnson &amp; Johnson Vision, it is indicated for the visual&#xD;
      correction of aphakia and pre-existing corneal astigmatism of one diopter or greater in adult&#xD;
      patients with or without presbyopia in whom a cataractous lens has been removed by&#xD;
      phacoemulsification and who desire reduction in residual refractive cylinder.&#xD;
&#xD;
      No study assessing the early rotational stability of the TECNIS® Eyhance Toric II IOL has&#xD;
      been published yet.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">April 2023</completion_date>
  <primary_completion_date type="Anticipated">April 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Single-center prospective cohort study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The mean of the best monocular uncorrected distance visual acuity UDVA (logMAR) at 1 month post-operative</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The mean of the best monocular corrected distance visual acuity (CDVA) (logMAR) preoperative (maximum 12 months before surgery)</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Cataract</condition>
  <condition>Astigmatism</condition>
  <arm_group>
    <arm_group_label>Patients operated with a TECNIS® Eyhance Toric II 1-piece posterior chamber lens</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>For at least one eye : Planned cataract surgery with placement of a TECNIS® Eyhance Toric II 1-piece posterior chamber lens</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Images of the operated eye (s)</intervention_name>
    <description>Through the operating microscope or a slit lamp, dilated pupil. Taken on the day of surgery (D0) and at 1 week, 1 month and 3 months post-op</description>
    <arm_group_label>Patients operated with a TECNIS® Eyhance Toric II 1-piece posterior chamber lens</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria&#xD;
&#xD;
          -  Aged ≥ 18 years&#xD;
&#xD;
          -  Patients scheduled for bilateral cataract surgery&#xD;
&#xD;
          -  For at least one eye :&#xD;
&#xD;
               -  Cataract surgery clinically indicated&#xD;
&#xD;
               -  Corneal astigmatism ≥ 1 D&#xD;
&#xD;
               -  Planned cataract surgery with placement of a TECNIS® Eyhance Toric II 1-piece&#xD;
                  posterior chamber lens&#xD;
&#xD;
        Non inclusion criteria&#xD;
&#xD;
          -  Pregnant or breast-feeding women&#xD;
&#xD;
          -  In the eye with planned cataract surgery with placement of a TECNIS® Eyhance Toric II&#xD;
             1-piece posterior chamber lens:&#xD;
&#xD;
               -  Irregular astigmatism (keratoconus suspicion)&#xD;
&#xD;
               -  Corneal scaring in visual axis&#xD;
&#xD;
               -  Retinal impairment that may limit visual recovery (macular degeneration, history&#xD;
                  of retinal detachment, etc.)&#xD;
&#xD;
               -  Visually impaired eye since childhood that cannot be improved despite correction&#xD;
                  of the refractive disorder&#xD;
&#xD;
               -  Any other ophthalmic disease inducing visual impairment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Luc FEBBRARO, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Fondation A. de Rothschild</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amélie YAVCHITZ, MD</last_name>
    <phone>+33148036433</phone>
    <email>ayavchitz@for.paris</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital Fondation A. de Rothschuld</name>
      <address>
        <city>Paris</city>
        <state>Hôpital Fondation A. De Rothschild</state>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Luc FEBBRARO, MD</last_name>
      <phone>+331 48 03 64 82</phone>
      <email>jlfebbraro@for.paris</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>November 10, 2021</study_first_submitted>
  <study_first_submitted_qc>December 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2021</study_first_posted>
  <last_update_submitted>December 2, 2021</last_update_submitted>
  <last_update_submitted_qc>December 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>TECNIS® Eyhance Toric II 1-piece posterior chamber lens</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Astigmatism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

